Literature DB >> 31744752

Amygdala subnucleus volumes in psychosis high-risk state and first-episode psychosis.

Reetta-Liina Armio1, Heikki Laurikainen2, Tuula Ilonen3, Maija Walta4, Raimo K R Salokangas3, Nikolaos Koutsouleris5, Jarmo Hietala2, Lauri Tuominen6.   

Abstract

Structural and functional abnormalities of the amygdala in schizophrenia have been well documented. Post-mortem studies suggest that the lateral nucleus is particularly affected in schizophrenia. It is not known whether the amygdala subnuclei are differently affected at the time of the first-episode psychosis or already at high-risk state. 75 first-episode psychosis patients (FEP), 45 clinical high-risk patients (CHR) and 76 population controls participated in this cross-sectional case-control study. Participants underwent T1-weighted 3T MRI scans, from which the amygdala was segmented using a newly developed automated algorithm. Because early adverse events increase risk for psychosis and affect the amygdala, we also tested whether experiences of childhood maltreatment associate with the putative amygdala subnuclei abnormalities. Compared to the population controls, FEP had smaller volumes of the lateral, and basal nuclei. In CHR, only the lateral nucleus was significantly smaller compared to the control subjects. Experience of childhood maltreatment was inversely associated with lateral nucleus volumes in FEP but not in CHR. These results show that the lateral and basal nuclei of the amygdala are already affected in FEP. These volumetric changes may reflect specific cellular abnormalities that have been observed in post-mortem studies in schizophrenia in the same subnuclei. Decreased volume of the lateral nucleus in CHR suggest that a smaller lateral nucleus could serve as a potential biomarker for psychosis risk. Finally, we found that the lateral nucleus volumes in FEP may be sensitive to the effects of childhood maltreatment.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amygdala subnuclei; Childhood maltreatment; Clinical high-risk; First-episode psychosis; MRI

Mesh:

Substances:

Year:  2019        PMID: 31744752     DOI: 10.1016/j.schres.2019.10.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  4 in total

1.  Childhood trauma and cognitive deficits in patients with schizophrenia: mediation by orbitofrontal cortex H-shaped sulci volume.

Authors:  Leilei Wang; Yi Yin; Wei Feng; Yanfang Zhou; Junchao Huang; Ping Zhang; Song Chen; Hongzhen Fan; Yimin Cui; Xingguang Luo; Shuping Tan; Zhiren Wang; Baopeng Tian; Li Tian; Chiang-Shan R Li; Yunlong Tan
Journal:  J Psychiatry Neurosci       Date:  2022-06-02       Impact factor: 5.699

2.  Differences in subcortical brain volumes among patients with schizophrenia and bipolar disorder and healthy controls.

Authors:  Kazutaka Ohi; Miori Ishibashi; Kaai Torii; Mayuka Hashimoto; Yurika Yano; Toshiki Shioiri
Journal:  J Psychiatry Neurosci       Date:  2022-03-01       Impact factor: 6.186

3.  Amygdala subnuclear volumes in temporal lobe epilepsy with hippocampal sclerosis and in non-lesional patients.

Authors:  Alice Ballerini; Manuela Tondelli; Francesca Talami; Maria Angela Molinari; Elisa Micalizzi; Giada Giovannini; Giulia Turchi; Marcella Malagoli; Maurilio Genovese; Stefano Meletti; Anna Elisabetta Vaudano
Journal:  Brain Commun       Date:  2022-09-06

4.  Nonclinical psychotic-like experiences and schizotypy dimensions: Associations with hippocampal subfield and amygdala volumes.

Authors:  Ulrika Evermann; Christian Gaser; Tina Meller; Julia-Katharina Pfarr; Sarah Grezellschak; Igor Nenadić
Journal:  Hum Brain Mapp       Date:  2021-07-24       Impact factor: 5.038

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.